Science Explorer Back to mapMap

Most cited papers from Pulmonx (United States)

What are the most cited papers from Pulmonx (United States)?

The most cited paper from Pulmonx (United States) is "A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE)" (Gerard J. Criner et al., 2018), with 445 citations. Next come "Predicting Lung Volume Reduction after Endobronchial Valve Therapy Is Maximized Using a Combination of Diagnostic Tools" (108) and "Diagnostic performance comparison of the C hartis S ystem and high‐resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction" (95).

Showing 23 of 23 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE) Gerard J. Criner et al. · American Journal of Respiratory and Critical Care Medicine Open access 22 May 2018 445
2 Predicting Lung Volume Reduction after Endobronchial Valve Therapy Is Maximized Using a Combination of Diagnostic Tools Theodoor David Koster, Eva M. van Rikxoort, Ralf-Harto Huebner et al. · Respiration 2016 108
3 Diagnostic performance comparison of the C hartis S ystem and high‐resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction Daniela Gompelmann, Ralf Eberhardt, Dirk‐Jan Slebos et al. · Respirology 25 Feb 2014 95
4 Technical Advances Surag Mantri, Chris Macaraeg, Sujith Shetty et al. · Journal of Bronchology & Interventional Pulmonology Apr 2009 35
5 Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical Trial Mark T. Dransfield, Justin L. Garner, Surya Prakash Bhatt et al. · Annals of the American Thoracic Society Open access 30 Mar 2020 28
6 Comparing Clinical Outcomes in Upper versus Lower Lobe Endobronchial Valve Treatment in Severe Emphysema Ralf Eberhardt, Felix J.F. Herth, Sri Radhakrishnan et al. · Respiration 2015 24
7 Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical Trial Ralf Eberhardt, Dirk‐Jan Slebos, Felix J.F. Herth et al. · Respiration Open access 2021 23
8 An adjusted and time-saving method to measure collateral ventilation with Chartis Theodoor David Koster, Karin Klooster, Hallie McNamara et al. · ERJ Open Research Open access 11 Jun 2021 15
9 Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves Theodoor David Koster, Pallav L. Shah, Arschang Valipour et al. · Respiratory Medicine Open access 18 Apr 2024 9
10 Patient Preferences for Endobronchial Valve Treatment of Severe Emphysema Carol A. Mansfield, Jessie Sutphin, Kelly Shriner et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2018 9
11 A multicenter, prospective, single-arm clinical investigation of a modified staged treatment algorithm using the AeriSeal system - The STAGE trial Theodoor David Koster, Ralf Eberhardt, Ralf‐Harto Hübner et al. · Respiratory Medicine Open access 15 Sep 2022 6
12 Lung volume reduction for emphysema using one-way endobronchial valves: An Australian cohort Calvin Sidhu, Nicholas Wilsmore, Narinder S. Shargill et al. · Medicine Open access 4 Aug 2023 5
13 Effect of Antifibrotic Therapy on Survival in Patients with Idiopathic Pulmonary Fibrosis Joao Alberto de Andrade, Megan Lee Neely, Anne S. Hellkamp et al. · SSRN Electronic Journal PreprintOpen access 2022 3
14 Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans Scott L. Shofer, Matthew Beyea, Sufeng Li et al. · BMJ Open Respiratory Research Open access Jun 2014 3
15 VT20 method for Chartis assessment of collateral ventilation with flexible bronchoscopy under procedural sedation Jacopo Saccomanno, Thomas Sgarbossa, Eva Pappe et al. · ERJ Open Research Open access 29 Feb 2024 1
16 Bronchoscopic Lung Volume Reduction with Zephyr Valves for Severe Emphysema Gerard J. Criner, Brian Armstrong, Narinder S. Shargill · Respiration 2021 1
17 B78-11 Application of a Residual Volume Calculator Using Spirometric Values to Predict Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease: Screening Candidates for Lung Volume Reduction K Hambleton, V Bhati, A Mowat et al. · American Journal of Respiratory and Critical Care Medicine May 2026 0
18 CASE REPORT: ULTRASOUND-GUIDED ERECTOR SPINAE PLANE BLOCK FOR PATIENTS UNDERGOING THORACOSCOPY FOR RIGHT PLEURAL EFFUSION Atif Mohammed, Nookala Vasudeva Rao, Peddi Srikanth · PARIPEX-INDIAN JOURNAL OF RESEARCH Open access 15 Jul 2025 0
19 Unsuspected Subclinical Left Ventricular Dysfunction in Post-COVID Patients: A Real-world Observation Parthasarathi Bhattacharyya, Sayoni Sengupta, Aniruddha De et al. · Journal of the Association of Physicians of India Open access Nov 2022 0
20 Improvements in Clinical Outcomes Associated with Reduction in Hyperinflation with Zephyr Valves Frank C. Sciurba, Richard D. Sue, Hiram Rivas-Perez et al. Conference paper 28 Sep 2019 0
21 Impact of endobronchial valves on patient reported outcomes in severe emphysema Mark T. Dransfield, Surya Prakash Bhatt, Dirk‐Jan Slebos et al. Conference paper 28 Sep 2019 0
22 Twelve-month positive outcomes of Zephyr endobronchial valves in severe emphysema patients: LIBERATE trial Dirk‐Jan Slebos et al. Conference paper 15 Sep 2018 0
23 Endoscopic Treatment of Emphysema Anupam Kumar, James K. Stoller, Michael S. Machuzak · Clinical Pulmonary Medicine 23 Jun 2016 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.